Annual D&A
$2.34 M
-$35.00 K-1.48%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual depreciation & amortization is $2.34 million, with the most recent change of -$35.00 thousand (-1.48%) on September 30, 2024.
- During the last 3 years, ENTA annual D&A has fallen by -$998.00 thousand (-29.93%).
- ENTA annual D&A is now -35.89% below its all-time high of $3.64 million, reached on September 30, 2020.
Performance
ENTA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$479.00 K
-$115.00 K-19.36%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly depreciation & amortization is $479.00 thousand, with the most recent change of -$115.00 thousand (-19.36%) on September 30, 2024.
- Over the past year, ENTA quarterly D&A has dropped by -$190.00 thousand (-28.40%).
- ENTA quarterly D&A is now -47.71% below its all-time high of $916.00 thousand, reached on June 30, 2020.
Performance
ENTA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.34 M
-$190.00 K-7.52%
September 30, 2024
Summary
- As of February 8, 2025, ENTA TTM depreciation & amortization is $2.34 million, with the most recent change of -$190.00 thousand (-7.52%) on September 30, 2024.
- Over the past year, ENTA TTM D&A has dropped by -$35.00 thousand (-1.48%).
- ENTA TTM D&A is now -35.89% below its all-time high of $3.64 million, reached on September 30, 2020.
Performance
ENTA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ENTA Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.5% | -28.4% | -1.5% |
| 3 y3 years | -29.9% | -40.6% | -29.9% |
| 5 y5 years | -28.3% | -40.6% | -29.9% |
ENTA Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.9% | at low | -41.7% | at low | -28.0% | at low |
| 5 y | 5-year | -35.9% | at low | -47.7% | at low | -35.9% | at low |
| alltime | all time | -35.9% | +1258.1% | -47.7% | +1268.6% | -35.9% | +4071.4% |
Enanta Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $2.34 M(-1.5%) | $479.00 K(-19.4%) | $2.34 M(-7.5%) |
| Jun 2024 | - | $594.00 K(-4.3%) | $2.53 M(-2.2%) |
| Mar 2024 | - | $621.00 K(-3.3%) | $2.58 M(+3.2%) |
| Dec 2023 | - | $642.00 K(-4.0%) | $2.50 M(+5.5%) |
| Sep 2023 | $2.37 M(-20.2%) | $669.00 K(+2.8%) | $2.37 M(+0.6%) |
| Jun 2023 | - | $651.00 K(+20.6%) | $2.36 M(-2.7%) |
| Mar 2023 | - | $540.00 K(+5.7%) | $2.42 M(-10.4%) |
| Dec 2022 | - | $511.00 K(-22.0%) | $2.70 M(-9.0%) |
| Sep 2022 | $2.97 M(-10.8%) | $655.00 K(-8.5%) | $2.97 M(-4.8%) |
| Jun 2022 | - | $716.00 K(-12.9%) | $3.12 M(-3.3%) |
| Mar 2022 | - | $822.00 K(+5.4%) | $3.23 M(-0.4%) |
| Dec 2021 | - | $780.00 K(-3.2%) | $3.24 M(-2.7%) |
| Sep 2021 | $3.33 M(-8.5%) | $806.00 K(-2.1%) | $3.33 M(-3.0%) |
| Jun 2021 | - | $823.00 K(-1.3%) | $3.44 M(-2.6%) |
| Mar 2021 | - | $834.00 K(-4.2%) | $3.53 M(-2.2%) |
| Dec 2020 | - | $871.00 K(-4.2%) | $3.61 M(-0.9%) |
| Sep 2020 | $3.64 M(+11.8%) | $909.00 K(-0.8%) | $3.64 M(+0.5%) |
| Jun 2020 | - | $916.00 K(+0.1%) | $3.63 M(+0.9%) |
| Mar 2020 | - | $915.00 K(+1.2%) | $3.60 M(+3.2%) |
| Dec 2019 | - | $904.00 K(+1.5%) | $3.48 M(+6.9%) |
| Sep 2019 | $3.26 M(+29.4%) | $891.00 K(+0.7%) | $3.26 M(+7.6%) |
| Jun 2019 | - | $885.00 K(+10.3%) | $3.03 M(+8.1%) |
| Mar 2019 | - | $802.00 K(+17.9%) | $2.80 M(+7.2%) |
| Dec 2018 | - | $680.00 K(+2.9%) | $2.61 M(+3.7%) |
| Sep 2018 | $2.52 M | $661.00 K(+0.6%) | $2.52 M(+4.0%) |
| Jun 2018 | - | $657.00 K(+7.2%) | $2.42 M(+4.5%) |
| Mar 2018 | - | $613.00 K(+4.4%) | $2.32 M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | $587.00 K(+4.1%) | $2.23 M(+4.4%) |
| Sep 2017 | $2.14 M(+28.7%) | $564.00 K(+2.2%) | $2.14 M(+5.4%) |
| Jun 2017 | - | $552.00 K(+4.5%) | $2.03 M(+6.2%) |
| Mar 2017 | - | $528.00 K(+7.1%) | $1.91 M(+5.2%) |
| Dec 2016 | - | $493.00 K(+8.4%) | $1.81 M(+9.3%) |
| Sep 2016 | $1.66 M(+159.9%) | $455.00 K(+4.8%) | $1.66 M(+17.8%) |
| Jun 2016 | - | $434.00 K(+0.2%) | $1.41 M(+23.6%) |
| Mar 2016 | - | $433.00 K(+27.7%) | $1.14 M(+34.4%) |
| Dec 2015 | - | $339.00 K(+66.2%) | $849.00 K(+32.9%) |
| Sep 2015 | $639.00 K(+81.5%) | $204.00 K(+23.6%) | $639.00 K(+17.2%) |
| Jun 2015 | - | $165.00 K(+17.0%) | $545.00 K(+16.5%) |
| Mar 2015 | - | $141.00 K(+9.3%) | $468.00 K(+15.3%) |
| Dec 2014 | - | $129.00 K(+17.3%) | $406.00 K(+15.3%) |
| Sep 2014 | $352.00 K(+59.3%) | $110.00 K(+25.0%) | $352.00 K(+11.7%) |
| Jun 2014 | - | $88.00 K(+11.4%) | $315.00 K(+9.4%) |
| Mar 2014 | - | $79.00 K(+5.3%) | $288.00 K(+12.1%) |
| Dec 2013 | - | $75.00 K(+2.7%) | $257.00 K(+16.3%) |
| Sep 2013 | $221.00 K(+28.5%) | $73.00 K(+19.7%) | $221.00 K(+18.2%) |
| Jun 2013 | - | $61.00 K(+27.1%) | $187.00 K(+16.1%) |
| Mar 2013 | - | $48.00 K(+23.1%) | $161.00 K(+3.9%) |
| Dec 2012 | - | $39.00 K(0.0%) | $155.00 K(-9.9%) |
| Sep 2012 | $172.00 K(-65.5%) | $39.00 K(+11.4%) | $172.00 K(+29.3%) |
| Jun 2012 | - | $35.00 K(-16.7%) | $133.00 K(+35.7%) |
| Mar 2012 | - | $42.00 K(-25.0%) | $98.00 K(+75.0%) |
| Dec 2011 | - | $56.00 K | $56.00 K |
| Sep 2011 | $499.00 K(-9.8%) | - | - |
| Sep 2010 | $553.00 K | - | - |
FAQ
- What is Enanta Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual D&A year-on-year change?
- What is Enanta Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly D&A year-on-year change?
- What is Enanta Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM D&A year-on-year change?
What is Enanta Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ENTA is $2.34 M
What is the all time high annual D&A for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual depreciation & amortization is $3.64 M
What is Enanta Pharmaceuticals annual D&A year-on-year change?
Over the past year, ENTA annual depreciation & amortization has changed by -$35.00 K (-1.48%)
What is Enanta Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ENTA is $479.00 K
What is the all time high quarterly D&A for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly depreciation & amortization is $916.00 K
What is Enanta Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ENTA quarterly depreciation & amortization has changed by -$190.00 K (-28.40%)
What is Enanta Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ENTA is $2.34 M
What is the all time high TTM D&A for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM depreciation & amortization is $3.64 M
What is Enanta Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ENTA TTM depreciation & amortization has changed by -$35.00 K (-1.48%)